Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival

Am J Cardiol. 2012 Nov 6;110(9 Suppl):58B-68B. doi: 10.1016/j.amjcard.2012.08.036.

Abstract

Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to leading causes of death, cancer and cardiovascular disease, including CAD, stroke, peripheral vascular disease, and other vascular disease. While glycemic management remains a cornerstone of DM care, the co-management of hypertension, atherosclerosis, cardiovascular risk reduction, and prevention of long-term consequences associated with DM are now well recognized as essential to improve long-term survival. Clinical trial evidence substantiates the importance of glycemic control, low-density cholesterol-lowering therapy, blood pressure lowering, control of albuminuria, and comprehensive approaches targeting multiple risk factors to reduce cardiovascular risk. This article presents a review of the role of DM in the pathogenesis of atherosclerosis and cardiac dysfunction, recent evidence on the degree of glycemic control and mortality, and available evidence for a multifaceted approach to improve long-term outcomes for patients.

Publication types

  • Review

MeSH terms

  • Albuminuria / prevention & control
  • Anticholesteremic Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Complications / mortality
  • Diabetes Complications / physiopathology
  • Diabetes Complications / therapy*
  • Exercise Therapy
  • Humans
  • Hyperglycemia / etiology
  • Hyperglycemia / prevention & control*
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents